What is Vitiligo?
Vitiligo is an acquired autoimmune depigmenting disorder characterized by white patches of skin resulting from the selective destruction and loss of melanocytes (pigment-producing cells). 1
Clinical Presentation
Vitiligo manifests as depigmented areas of otherwise normal-appearing skin. The disease typically begins after birth, with an average age of onset around 20 years, though it can develop in childhood 1.
Two Main Clinical Subtypes:
Non-segmental (symmetrical) vitiligo: The most common form, producing symmetrical depigmented patches that typically affect:
- Fingers and wrists
- Axillae and groins
- Body orifices (mouth, eyes, genitalia)
- Face and acral regions 1
Segmental vitiligo: Less common variant confined to one unilateral segment, following a dermatomal distribution or Blaschko's lines 1
Key Clinical Features:
- White patches with no surface changes and usually no redness 1
- May show "trichrome" appearance with white center and intermediate pale area around it 1
- Can affect hair follicle melanocytes, causing white eyelashes and hair within patches 1
- Mucosal involvement possible, particularly prominent in darkly pigmented individuals 1
Pathophysiology
Vitiligo is fundamentally an autoimmune disease with strong evidence supporting immune-mediated melanocyte destruction 1. The pathogenesis involves:
- Autoreactive cytotoxic CD8+ T cells targeting melanocytes 2
- IFN-γ production driving disease progression 2
- Cellular stress, innate immune activation, and adaptive immune responses 3
- Tissue-resident memory T cells playing a central role in disease persistence and relapse 3, 2
Genetic and Environmental Factors:
- Shows familial trait in approximately 18% of cases 1
- Genetic polymorphisms linked to immune response and melanogenesis pathways 3
- Environmental factors contribute to disease onset 3
Associated Conditions
Patients with vitiligo frequently develop autoimmune thyroid disease and other autoimmune conditions 1. In one series, 34% of adults had autoimmune thyroid disease 1. Other associations include:
- Thyroid dysfunction
- Rheumatoid arthritis
- Diabetes mellitus
- Alopecia areata 4
Psychological Impact
The psychological burden of vitiligo is substantial and must not be underestimated. The visible nature of the condition causes:
- Low self-esteem
- Social anxiety and depression
- Stigmatization
- In extreme cases, social rejection 1
- Significant impairment in quality of life 3, 5
This psychosocial impact is particularly severe in individuals with darker skin types where the contrast is more pronounced 4.
Diagnosis
Diagnosis is typically straightforward and clinical in classical symmetrical presentations 1. Laboratory tests or biopsies are rarely required 3.
Diagnostic Approach:
- Classical symmetrical vitiligo: Can be diagnosed confidently in primary care 1
- Atypical presentations: Require expert dermatologist assessment 1
- Wood's light examination: May help delineate depigmented areas, especially in pale skin types I-II 1
- Thyroid function testing: Should be considered given high prevalence of autoimmune thyroid disease 1
Epidemiology
Vitiligo affects approximately 0.36% of the global population 3, with prevalence around 1% in the United States and Europe, ranging from <0.1% to >8% worldwide 4. Half of all patients develop disease before age 20 4. The recorded female predominance may reflect greater willingness to seek care for cosmetic concerns 4.
Disease Course
The course of vitiligo is unpredictable and often progressive 1, 6. Spontaneous repigmentation occurs in only 10-20% of cases, mainly in children, and tends to be partial and limited to sun-exposed areas 6. In individuals with very pale skin (types I-II), vitiligo may cause minimal cosmetic concern 1.